New quinazolinone-pyrimidine hybrids: Synthesis, anti-inflammatory, and ulcerogenicity studies

被引:93
作者
Abbas, Safinaz E. [1 ]
Awadallah, Fadi M. [1 ]
Ibrahin, Nashwa A. [2 ]
Said, Eman G. [2 ]
Kamel, Gihan M. [3 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
[2] Beni Suef Univ, Fac Pharm, Dept Pharmaceut Chem, Bani Suwayf 62111, Egypt
[3] Cairo Univ, Fac Vet Med, Dept Pharmacol, Cairo 11562, Egypt
关键词
Quinazolinone; Pyrimidine; Dihydropyrimidine; Anti-inflammatory activity; COX-1/COX-2; Ulcerogenicity; GASTROINTESTINAL TOXICITY; DERIVATIVES SYNTHESIS; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; CYCLOOXYGENASE-2; POTENT; INHIBITION; ASPIRIN; DESIGN;
D O I
10.1016/j.ejmech.2012.03.050
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Two groups of hybrid compounds: the quinazolinone dihydropyrimidines and quinazolinone pyrimidines, were synthesized. The starting derivative 3 was reacted with chloroacetyl chloride to give intermediate 5 which was condensed with the 2-mercaptopyrimidines 4a-c affording compounds 6a-c. These latter compounds underwent hydrolysis and N-alkylation reactions to give the dihydropyrimidine derivatives 7a-c and 8a-f, respectively. The chloro derivatives 9a-c subsequently reacted with various anilines furnishing compounds 10a-i. The anti-inflammatory activity of the synthesized compounds were evaluated using the carrageenan-induced rat paw oedema model and ulcer indices for the most active compounds were calculated. Five compounds were found more active and less ulcerogenic than diclofenac particularly compound 10g (IC50 = 116.73 mu mol/kg; ulcer index = 11.38). Compound 10g was also 2-fold more selective inhibitor of COX-2 than COX-1. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:141 / 149
页数:9
相关论文
共 45 条
[1]
Novel substituted and fused pyrrolizine derivatives: Synthesis, anti-inflammatory and ulcerogenecity studies [J].
Abbas, Safinaz E. ;
Awadallah, Fadi M. ;
Ibrahim, Nashwa A. ;
Gouda, Ahmed M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) :482-491
[2]
Abbas SES, 2007, B PHARM SCI, V30, P51
[3]
Synthesis, biological evaluation and molecular docking of novel series of spiro [(2H,3H) quinazoline-2,1′- cyclohexan]-4(1H)- one derivatives as anti-inflammatory and analgesic agents [J].
Amin, K. M. ;
Kamel, M. M. ;
Anwar, M. M. ;
Khedr, M. ;
Syam, Y. M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) :2117-2131
[4]
[Anonymous], J MED CHEM
[5]
Archana, 2002, INDIAN J CHEM B, V41, P2371
[6]
Atsuo B., 1996, J MED CHEM, V39, P5176, DOI DOI 10.1021/JM9509408
[7]
Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines [J].
Balakumar, C. ;
Lamba, P. ;
Kishore, D. Pran ;
Narayana, B. Lakshmi ;
Rao, K. Venkat ;
Rajwinder, K. ;
Rao, A. Raghuram ;
Shireesha, B. ;
Narsaiah, B. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) :4904-4913
[8]
Structure-based design of COX-2 selectivity into flurbiprofen [J].
Bayly, CI ;
Black, WC ;
Léger, S ;
Ouimet, N ;
Ouellet, M ;
Percival, MD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) :307-312
[9]
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors [J].
Black, WC ;
Bayly, C ;
Belley, M ;
Chan, CC ;
Charleson, S ;
Denis, D ;
Gauthier, JY ;
Gordon, R ;
Guay, D ;
Kargman, S ;
Lau, CK ;
Leblanc, Y ;
Mancini, J ;
Ouellet, M ;
Percival, D ;
Roy, P ;
Skorey, K ;
Tagari, P ;
Vickers, P ;
Wong, E ;
Xu, L ;
Prasit, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) :725-730
[10]
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528